MediXall (MDXL) Operating Income (2019 - 2024)
MediXall's Operating Income history spans 6 years, with the latest figure at $263813.0 for Q3 2024.
- For Q3 2024, Operating Income rose 129.05% year-over-year to $263813.0; the TTM value through Sep 2024 reached -$2.2 million, up 55.78%, while the annual FY2023 figure was -$4.6 million, 418.14% down from the prior year.
- Operating Income reached $263813.0 in Q3 2024 per MDXL's latest filing, up from -$485862.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $263813.0 in Q3 2024 to a low of -$2.4 million in Q1 2022.
- Average Operating Income over 3 years is -$1.1 million, with a median of -$1.1 million recorded in 2022.
- Peak YoY movement for Operating Income: rose 16.22% in 2023, then skyrocketed 129.05% in 2024.
- A 3-year view of Operating Income shows it stood at -$1.8 million in 2022, then rose by 18.4% to -$1.5 million in 2023, then soared by 118.14% to $263813.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Operating Income are $263813.0 (Q3 2024), -$485862.0 (Q2 2024), and -$486600.0 (Q1 2024).